Skip to main content

Juvenile Idiopathic Arthritis clinical trials at UCSF
2 in progress, 1 open to new patients

  • Start Time Optimization of Biologics in Polyarticular JIA

    open to eligible people ages 2–18

    STOP-JIA is a PCORI funded prospective observational study which will compare the clinical effectiveness and impact on patient reported outcomes of 3 Childhood Arthritis & Rheumatology Research Alliance (CARRA) consensus derived treatment strategies (CTPs) in new-onset polyarticular JIA (pJIA) patients to answer the critical question of when is the best time to begin biologic medications to achieve the optimal clinical and patient reported outcomes. Because the CARRA Registry will be used for data collection, all patients will be enrolled in the CARRA Registry. The standard of care treatments are chosen by the treating physician and patient/caregiver and are not randomized.

    San Francisco, California and other locations

  • Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis

    Sorry, not currently recruiting here

    Evaluate long-term safety and tolerability of tofacitinib in patients with JIA, who have previously participated in tofacitinib JIA studies.

    San Francisco, California and other locations